Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Compare both ixekizumab regimens (80 mg every 2 weeks [Q2W] or 80 mg every 4 weeks [Q4W]) versus placebo in patients with active nonradiographic axial spondyloarthritis (nonrad-axSpA) at Week 16
Critère d'inclusion
- bDMARD Naive Patients with Nonradiographic Axial Spondyloarthritis